Zoetis | ZTS - Cost Of Sales


Zoetis reported $704M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
AbbVie USD 4.29B 73M Jun/2026
Align Technology USD 298.76M 4.74M Jun/2026
Bayer EUR 4.54B 692M Jun/2026
Bristol-Myers Squibb USD 7.89B 4.03B Jun/2026
Charles River Laboratories USD 655.29M 61.22M Jun/2026
Coherus Biosciences USD 4.04M 324K Dec/2025
Dentsply International USD 405M 48M Jun/2026
Eli Lilly USD 3.27B 309M Jun/2026
Henry Schein USD 2.43B 129M Jun/2026
Idexx Laboratories USD 437.5M 19.42M Jun/2026
Illumina USD 389M 19M Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
J&J USD 8B 67M Jun/2026
Laboratory Of America USD 2.7B 97.8M Jun/2026
Merck USD 3.14B 200M Jun/2026
Neogen USD 117.5M 5.3M Mar/2026
Pacira USD 58.49M 7.75M Jun/2026
Perrigo USD 708.9M 65.2M Jun/2026
Pfizer USD 4.09B 498M Jun/2026
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Quest Diagnostics USD 2.05B 64M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026
Sanofi EUR 3.14B 618M Mar/2026
Zoetis USD 704M 32M Jun/2026